Loading...
Healthcare Triangle Inc (HCTI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock is showing bearish technical indicators, lacks positive catalysts, and has poor financial performance despite revenue growth. Additionally, the recent reverse stock split to meet Nasdaq requirements suggests potential instability.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. RSI indicates oversold conditions at 4.738, and the MACD histogram is above 0 but positively contracting. The stock is trading near its support level (S1: 7.946), with significant downside risk as indicated by the next support (S2: 5.389).
Revenue increased by 44.59% YoY in Q3 2025, and gross margin improved slightly by 1.27% YoY.
The company announced a 1-for-60 reverse stock split to comply with Nasdaq's $1 minimum bid requirement, which may indicate financial instability. EPS dropped by -99.22% YoY, and net income remains negative despite improvement.
In Q3 2025, revenue increased to $3,489,000 (up 44.59% YoY), but net income remains negative at -$1,906,000 (up 52.60% YoY). EPS dropped significantly to -0.43 (-99.22% YoY), and gross margin improved slightly to 15.91%.
No recent analyst ratings or price target changes available.
